Binaltorphimine
![]() | |
| Clinical data | |
|---|---|
| ATC code | None |
| Identifiers | |
| |
| CAS Number | 105618-27-7 |
| PubChem (CID) | 5484197 |
| ChemSpider | 24673307 |
| ChEMBL | CHEMBL610001 |
| Chemical and physical data | |
| Formula | C41H45N3O6 |
| Molar mass | 675.813 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Binaltorphimine (BNI) is a selective antagonist of the κ-opioid receptor (KOR).[1] BNI and norbinaltorphimine (nor-BNI) were the first highly selective KOR antagonists to be discovered.[1]
See also
References
This article is issued from Wikipedia - version of the 7/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
